Chart Audit for Statin Therapy for Cardiovascular Disease Measure
Chart audit template for confirming whether high-risk cardiovascular patients were prescribed or remained on statin therapy during the measurement period. Use it to document eligibility, therapy evidence, exceptions, and follow-up actions in one review.
Trusted by frontline teams 15 years of frontline software AI customization in seconds
Built for: Primary Care · Cardiology · Population Health · Health System Quality · Value Based Care
Overview
This chart audit template is built for reviewing whether a patient who meets the cardiovascular risk criteria was prescribed or remained on statin therapy during the measurement period. It walks the reviewer through audit details, clinical eligibility, evidence of therapy, exceptions, and close-out actions so the final result is traceable and easy to act on.
Use it when you need to verify measure compliance from the chart, not just from a medication list summary. The template is useful for quality reporting, internal audits, gap closure work, and retrospective chart abstraction where the reviewer must confirm the diagnosis or risk factor, check the most recent lipid data or ASCVD risk score if documented, and identify whether statin therapy was active, renewed, or otherwise supported in the record.
Do not use it as a general medication reconciliation form or for patients who are clearly outside the measure age range or eligibility criteria. It is also not the right tool when the chart lacks enough source documentation to support a defensible audit finding; in that case, the deficiency should be recorded and escalated for follow-up. The template is designed to separate true non-conformance from valid contraindications, intolerance, or documented exceptions, which helps teams avoid false gaps and focus corrective action where it is actually needed.
Standards & compliance context
- This template supports quality review workflows commonly used in value-based care and aligns with the documentation discipline expected in clinical quality programs.
- The eligibility and therapy fields help reviewers apply measure logic consistently with recognized cardiovascular quality standards and internal audit protocols.
- The contraindication and exception section supports defensible documentation practices consistent with clinician judgment, shared decision-making, and medical record review expectations.
- If your organization maps this audit to external reporting, validate the measure logic against the current program specifications and your EHR abstraction rules before use.
General regulatory context for orientation only — verify current requirements with counsel or the relevant agency before relying on this template for compliance.
What's inside this template
Audit Details and Measurement Period
This section anchors the review to a specific patient, reviewer, and reporting window so the audit result is traceable.
-
Patient chart and measurement period are identified
Record the patient identifier, audit date, and measurement period being reviewed.
-
Patient falls within the measure age range
Verify the patient is within the applicable age range for the statin measure during the measurement period.
-
Measurement period is clearly documented
Confirm the chart review uses the correct measurement period dates and encounter window.
-
Audit source records reviewed
Select the chart sources reviewed for evidence.
Clinical Eligibility and Risk Identification
This section confirms the patient actually belongs in the measure before any medication finding is counted.
-
ASCVD diagnosis or qualifying cardiovascular risk is documented
Confirm chart evidence of ASCVD, high LDL-C, or other qualifying cardiovascular risk criteria used by the measure.
-
Relevant diagnosis or risk factor is present in the problem list or assessment
Verify the qualifying condition is documented in the problem list, assessment, or active diagnosis history.
-
Most recent lipid data reviewed
Confirm the chart contains recent lipid results or documented rationale if labs were not available.
-
LDL-C value, if applicable
Enter the most recent LDL-C value used for the audit, if available.
-
ASCVD risk score, if documented
Enter the documented ASCVD risk score if the chart uses risk-based eligibility.
Statin Therapy Evidence
This section captures the chart proof that statin therapy was prescribed, active, or renewed during the measurement period.
-
Statin therapy is documented during the measurement period
Verify the chart shows a statin prescription, active medication, or documented use during the measurement period.
-
Statin medication name and dose are documented
Enter the statin name and dose as documented in the chart.
-
Therapy is active or renewed during the measurement period
Confirm the medication was active, renewed, or otherwise current during the measurement period.
-
Evidence source for statin therapy
Select the strongest source of evidence supporting statin therapy.
-
Adherence or tolerance concerns documented
Verify whether the chart documents adherence barriers, side effects, or tolerance concerns that may affect therapy continuity.
Contraindications, Exclusions, and Exceptions
This section separates valid clinical exceptions from missing documentation so false gaps are avoided.
-
Statin contraindication or intolerance is documented
Confirm whether the chart documents a contraindication, intolerance, or other valid exception.
-
Specific exception reason is documented
Select the documented reason for non-use or exclusion, if applicable.
-
Exception is supported by chart evidence
Verify the reason is supported by clinician documentation, labs, allergy list, or external records.
-
Shared decision-making or counseling documented
Confirm counseling, risk/benefit discussion, or patient refusal documentation is present when therapy is not used.
Close-Out and Corrective Actions
This section turns the audit into action by recording the outcome, deficiency summary, and follow-up owner.
-
Audit outcome recorded
Select the final audit outcome.
-
Deficiency or gap summary
Summarize any missing evidence, documentation gaps, or measure failures.
-
Corrective action required
Indicate whether follow-up is needed to address documentation or care gaps.
-
Follow-up owner and due date
Enter the person or team responsible and the expected completion date for follow-up.
How to use this template
- Enter the patient chart identifier, measurement period, reviewer name, and source records before you begin the audit so the review is tied to a specific reporting window.
- Confirm that the patient falls within the measure age range and has documented ASCVD or another qualifying cardiovascular risk factor before evaluating medication evidence.
- Review the problem list, assessment, lipid results, and any ASCVD risk score documentation to verify that the patient meets the clinical eligibility criteria for the measure.
- Check the medication list, prescription history, renewal notes, and encounter documentation for the statin name, dose, and evidence that therapy was active during the measurement period.
- Record any contraindication, intolerance, or exception reason with supporting chart evidence and note whether shared decision-making or counseling was documented.
- Close the audit by marking the outcome, summarizing the deficiency or gap, assigning the corrective action owner, and setting a due date for follow-up.
Best practices
- Use the most recent chart evidence available within the measurement period, and note the date of every source you rely on.
- Treat a missing statin dose or medication name as a documentation deficiency, not as proof that therapy was absent.
- Separate eligibility review from therapy review so you do not count a patient as non-compliant before confirming they actually meet the measure.
- Flag contraindications and intolerance only when the chart contains specific supporting evidence, such as documented adverse effects or clinician rationale.
- Capture the exact source of evidence, such as the medication list, encounter note, refill record, or specialist documentation, so the audit can be defended later.
- Document whether the statin was active, renewed, or newly prescribed during the measurement period, since a historical prescription alone may not satisfy the measure.
- Assign corrective actions to a named owner with a due date so the audit produces follow-through instead of a static finding.
What this template typically catches
Issues teams running this template most often surface in practice:
Common use cases
Frequently asked questions
Who should use this chart audit template?
Quality teams, clinical auditors, care coordinators, and practice managers can use it to review charts against a statin therapy measure. It is especially useful when you need a repeatable way to verify whether a patient met the measure through active therapy, renewal, or a documented exception. The template also helps clinicians see exactly what evidence was present in the chart.
What patient population does this audit apply to?
This template is for patients who fall within the measure age range and have documented ASCVD or another qualifying cardiovascular risk profile. It is not meant for every primary care chart, only those that need to be tested against the statin quality measure. If the patient is outside the age band or does not meet the risk criteria, the audit should stop at eligibility.
How often should this audit be run?
Run it on a cadence that matches your quality reporting cycle, such as monthly, quarterly, or at the end of the measurement period. Many teams also use it during pre-submission chart review so gaps can be corrected before reporting closes. The right frequency depends on how often your organization updates medication lists and closes care gaps.
What evidence counts as proof of statin therapy?
Acceptable evidence usually includes an active medication list, a recent prescription, a renewal during the measurement period, or chart notes that clearly document the statin name and dose. The template prompts reviewers to capture the source of evidence so the finding is defensible. If the chart only suggests therapy indirectly, that should be flagged as a deficiency rather than assumed.
How does this template handle contraindications or intolerance?
It includes a dedicated section for contraindications, intolerance, and exception reasons so reviewers can distinguish a true gap from a valid exclusion. The chart should show the specific reason, supporting evidence, and any counseling or shared decision-making documented by the clinician. If the exception is not supported in the record, it should be treated as an unresolved gap.
What are the most common mistakes this audit catches?
Common issues include missing statin dose documentation, outdated medication lists, risk factors buried in notes but not reflected in the problem list, and exceptions without chart support. Reviewers also often find that the patient qualifies for the measure but the most recent lipid data or ASCVD risk score was never documented. The template is designed to surface those gaps consistently.
Can this template be customized for our EHR or quality program?
Yes. You can add fields for your EHR source, local measure ID, reviewer name, or internal escalation workflow without changing the core audit logic. Many teams also customize the evidence sources to match how their organization documents prescriptions, refill history, and clinician attestations.
How is this different from a manual chart review checklist?
A manual checklist often stops at yes/no answers and leaves out the evidence trail needed for follow-up. This template organizes the review from eligibility through close-out, so the reviewer captures the exact chart basis for the finding, the gap summary, and the corrective action owner. That makes it easier to trend issues and resolve them before reporting.
Related templates
Go deeper on the topic
-
A daily huddle is a brief (10–15 minute) standing meeting held at the start of a shift or workday to align the team on priorities, surface issues, and...
-
A deskless worker is any employee whose job happens without a desk, a company laptop, or a fixed workstation. They're roughly 80% of the global workforce —...
-
A frontline employee app is a phone-first application that gives hourly, field, and deskless workers access to their schedule, pay, announcements, training,...
-
A frontline worker is any employee whose job happens away from a desk — on a production floor, in a patient room, behind a store counter, in a customer's...
-
Software bloat warning signs explained—spot bloated software early and choose leaner tools that boost performance, adoption, and ROI.
-
Spring '26 adds real-time Google & Outlook calendar sync, Google Workspace file creation in Files, upgraded Messenger, and expanded mobile parity.
-
Learn how nonprofit tracking of KPIs, donations, and operational workflows reduces turnover and improves decision-making with the right knowledge management...
-
Learn how AI-driven workflows close compliance gaps in hiring, field inspections, and compensation — before they become audit findings.
Ready to use this template?
Get started with MangoApps and use Chart Audit for Statin Therapy for Cardiovascular Disease Measure with your team — pricing built for small business.
